Paper40338652
Drug-Induced Liver Injury with Novel Fat Burner AlbutarexV2 in an Active Duty Sailor.
Lilley LJ and 2 others. Mil Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Drug-Induced Liver Injury with Novel Fat Burner AlbutarexV2 in an Active Duty Sailor. Papers, record 40338652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40338652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Obesity Agents | Major topic |
| Chemical and Drug Induced Liver Injury | Major topic |
| Dietary Supplements | Major topic |
| Military Personnel | Major topic |
| Humans | |
| Male | |
| Young Adult |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30253139 | The epidemiology of obesity. | Metabolism | 2019 | https://conductscience.org/library/papers/30253139 | PubMed |
| 2 | 31375101 | Herbal supplements in the print media: communicating benefits and risks. | BMC Complement Altern Med | 2019 | https://conductscience.org/library/papers/31375101 | PubMed |
| 3 | 26205799 | Effect of piperine on liver function of CF-1 albino mice. | Infect Disord Drug Targets | 2015 | https://conductscience.org/library/papers/26205799 | PubMed |
| 4 | 33663653 | Dietary Supplement Use Among Adults: United States, 2017-2018. | NCHS Data Brief | 2021 | https://conductscience.org/library/papers/33663653 | PubMed |
| 5 | 38803590 | Exploring Acute Liver Damage: Slimming Health Foods and CYP3A4 Induction. | Yonago Acta Med | 2024 | https://conductscience.org/library/papers/38803590 | PubMed |
| 6 | 31396080 | Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31396080 | PubMed |
| 7 | 30421981 | Current regulatory guidelines and resources to support research of dietary supplements in the United States. | Crit Rev Food Sci Nutr | 2020 | https://conductscience.org/library/papers/30421981 | PubMed |
| 8 | 28443154 | Drug-induced liver injury: Do we know everything? | World J Hepatol | 2017 | https://conductscience.org/library/papers/28443154 | PubMed |
| 9 | 27956449 | Drug-induced liver injury. | Clin Med (Lond) | 2016 | https://conductscience.org/library/papers/27956449 | PubMed |
| 10 | 32192741 | Acute Liver Failure Caused by Use of Fat Burner: A Case Report. | Transplant Proc | 2020 | https://conductscience.org/library/papers/32192741 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40338652
GET https://conductscience.org/api/papers/v1/40338652/authors